RSSCognition

Frontiers in Detecting Consciousness: The Growing Use of EEG Analysis

Frontiers in Detecting Consciousness: The Growing Use of EEG Analysis

| August 18, 2020

Dear Editors: There is growing scientific interest regarding the use of electroencephalogram (EEG) and multivariate analysis as a means to classify states of consciousness. A recent work assessed the validity of 28 potential EEG markers of consciousness, using the Disorders of Consciousness (DoC)-Forest (the name of the algorithm) tool, to establish states of awareness in a […]

Continue Reading

Increased Levels of Protein-methionine Sulfoxide in Plasma Correlate with a Shift from a Mild Cognitive Impairment to an Alzheimer’s Disease Stage

Increased Levels of Protein-methionine Sulfoxide in Plasma Correlate with a Shift from a Mild Cognitive Impairment to an Alzheimer’s Disease Stage

| July 1, 2019

Continue Reading

Does Vitamin D Deficiency Contribute to Cognitive Dysfunction in Patients with Systemic Lupus Erythematosus?

Does Vitamin D Deficiency Contribute to Cognitive Dysfunction in Patients with Systemic Lupus Erythematosus?

| October 1, 2018

Continue Reading

The Benefit of Mirtazapine in the Treatment of Progressive Multifocal Leukoencephalopathy in a Young HIV-positive Patient: A Case Report

The Benefit of Mirtazapine in the Treatment of Progressive Multifocal Leukoencephalopathy in a Young HIV-positive Patient: A Case Report

| February 1, 2018 | 0 Comments

by Carola Mullins, MD; Jorge Miranda, MS; Hugo Sandoval, PhD; Luis Ramos-Duran, MD; and Silvina B. Tonarelli, MD Drs. Mullins , Sandoval, and Ramos-Duran are with the Department of Radiology, Dr. Miranda is with the Paul Foster School of Medicine, and Dr. Tonarelli is with the Department of Psychiatry— all with Texas Tech University Health […]

Continue Reading

Cognitive Impairment Associated with Cancer: A Brief Review

Cognitive Impairment Associated with Cancer: A Brief Review

| February 1, 2018 | 0 Comments

by J. Cara Pendergrass, PhD; Steven D. Targum, MD; and John E. Harrison, BSc (hons), PhD, Cpsychol, CSCI Drs. Pendergrass and Targum are with Bracket Global and Clintara LLC, A Bracket Company, in Boston, Massachusetts. Dr. Harrison is with the Alzheimer’s Center and Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Center in Amsterdam, […]

Continue Reading

Letter to the editor: Marijuana on the brain— a concern

Letter to the editor: Marijuana on the brain— a concern

| February 1, 2018 | 0 Comments

Continue Reading

Letter to the editor: Stroke Telerehabilitation in Sicily: a cost-effective approach to reduce disability?

Letter to the editor: Stroke Telerehabilitation in Sicily: a cost-effective approach to reduce disability?

| February 1, 2018 | 0 Comments

Continue Reading

CNS Summit 2017 Abstracts of Poster Presentations

CNS Summit 2017 Abstracts of Poster Presentations

| November 1, 2017 | 0 Comments

Innov Clin Neurosci. 2017;14(11–12)S1—S20

Continue Reading

Outcomes Assessment in Clinical Trials of Alzheimer’s Disease and its Precursors: Readying for Short-term and Long-term Clinical Trial Needs

Outcomes Assessment in Clinical Trials of Alzheimer’s Disease and its Precursors: Readying for Short-term and Long-term Clinical Trial Needs

| February 1, 2017 | 0 Comments

by Holly Posner, MD, MS; Rosie Curiel, PsyD; Chris Edgar, PhD; Suzanne Hendrix, PhD; Enchi Liu, PhD; David A. Loewenstein, PhD; Glenn Morrison, MSc, PhD; Leslie Shinobu, PhD; Keith Wesnes, BSc, PhD, FSS, CPsychol, FBPsS; and Philip D. Harvey, PhD Dr. Posner is with Pfizer Inc., New York, New York; Drs. Curiel, Loewenstein, and Harvey […]

Continue Reading